BSE Live
Feb 08, 16:01Prev. Close
393.45
Open Price
398.90
Bid Price (Qty.)
394.40 (16)
Offer Price (Qty.)
397.00 (1)
NSE Live
Feb 08, 16:09Prev. Close
393.40
Open Price
394.95
Bid Price (Qty.)
394.30 (41)
Offer Price (Qty.)
0.00 (0)
Nine Months Results of Aarti Drugs (in Rs. Cr.) | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
Net Sales/Income from operations | 1,801.56 | 1,609.69 | 1,462.81 | 1,228.35 | 1,021.71 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | 1,801.56 | 1,609.69 | 1,462.81 | 1,228.35 | 1,021.71 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 1,267.05 | 1,087.93 | 851.39 | 806.76 | 700.29 | |
Purchase of Traded Goods | 39.58 | 43.19 | 29.87 | 29.84 | 24.21 | |
Increase/Decrease in Stocks | -51.39 | -65.96 | -2.58 | -28.93 | -47.06 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 53.89 | 51.25 | 52.32 | 44.14 | 38.89 | |
Depreciation | 35.62 | 35.51 | 35.94 | 34.68 | 30.11 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 298.54 | 259.20 | 208.92 | 199.73 | 158.58 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 158.27 | 198.57 | 286.95 | 142.13 | 116.69 | |
Other Income | 1.30 | 4.15 | 5.57 | 0.44 | 1.25 | |
P/L Before Int., Excpt. Items & Tax | 159.57 | 202.72 | 292.52 | 142.57 | 117.94 | |
Interest | 24.18 | 14.22 | 18.27 | 24.96 | 27.83 | |
P/L Before Exceptional Items & Tax | 135.39 | 188.50 | 274.25 | 117.61 | 90.11 | |
Exceptional Items | -- | -- | 0.22 | -- | -- | |
P/L Before Tax | 135.39 | 188.50 | 274.47 | 117.61 | 90.11 | |
Tax | 35.75 | 46.50 | 67.00 | 38.50 | 28.55 | |
P/L After Tax from Ordinary Activities | 99.64 | 142.00 | 207.47 | 79.11 | 61.56 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 99.64 | 142.00 | 207.47 | 79.11 | 61.56 | |
Equity Share Capital | 92.60 | 92.60 | 93.20 | 23.30 | 23.58 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 10.76 | 15.31 | 22.26 | 33.83 | 26.11 | |
Diluted EPS | 10.76 | 15.31 | 22.26 | 33.83 | 26.11 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 10.76 | 15.31 | 22.26 | 33.83 | 26.11 | |
Diluted EPS. | 10.76 | 15.31 | 22.26 | 33.83 | 26.11 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
28.01.2023
Aarti Drugs Consolidated December 2022 Net Sales at Rs 663.96 crore, up 4.59% Y-o-Y
27.01.2023
Aarti Drugs Standalone December 2022 Net Sales at Rs 625.53 crore, up 5.45% Y-o-Y
20.10.2022
Aarti Drugs Standalone September 2022 Net Sales at Rs 624.83 crore, up 22.35% Y-o-Y
20.10.2022
Aarti Drugs Consolidated September 2022 Net Sales at Rs 687.72 crore, up 18.65% Y-o-Y
28.01.2023
Aarti Drugs Consolidated December 2022 Net Sales at Rs 663.96 crore, up 4.59% Y-o-Y
27.01.2023
Aarti Drugs Standalone December 2022 Net Sales at Rs 625.53 crore, up 5.45% Y-o-Y
20.10.2022
Aarti Drugs Standalone September 2022 Net Sales at Rs 624.83 crore, up 22.35% Y-o-Y
20.10.2022
Aarti Drugs Consolidated September 2022 Net Sales at Rs 687.72 crore, up 18.65% Y-o-Y